Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
Clinical trial NCT01834638 · TERMINATED
Trial details
- NCT number
- NCT01834638
- Sponsor
- AbbVie
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-01
- Primary completion
- 2014-11-01
- Enrollment
- 268
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.